SPIMACO executives visited Al-Qassim National Hospital to explore collaboration opportunities, discuss healthcare innovations, and reinforce commitments to excellence and future healthcare projects.
SPIMACO announces the launch of SPIMACO Bio, a new subsidiary focused on biologic, genetic, and cell-based therapies, supporting advanced pharmaceutical manufacturing, knowledge transfer, and sustainable growth in the Kingdom, pending regulatory approvals.
SPIMACO participated in the Generic Medicines Conference organized by SFDA. The participation highlighted local success stories, R&D insights, and SPIMACO’s commitment to advancing generic medicines, innovation, and sustainable pharmaceutical growth.
Mr. Tami Al‑Tami, Executive Manager at SPIMACO, participated in a workshop on smart pharmaceutical manufacturing during the Made in Saudi 2025 exhibition, highlighting SPIMACO’s leadership in innovation and advanced technologies.
Prof. Ahmed Aljedai, Vice Chairman and Managing Director of SPIMACO, participated in a panel discussion titled “The Pharmacist as a Provider” at the IHOP7 Conference, highlighting the vital role of pharmacists in advancing healthcare, innovation, and patient-centered pharmaceutical services.
